Xarelto (generic name rivaroxaban) is a prescription blood thinner manufactured by Janssen Pharmaceuticals (a subsidiary of Johnson & Johnson) and Bayer Healthcare.
The drug is approved by the United States Food and Drug Administration (FDA) to:
Reduce the risk of stroke and blood clots in patients with nonvalvular atrial fibrillation (irregular heartbeat) and in patients who recently had knee or hip replacement, and
Treat deep vein thrombosis and pulmonary embolism.
Since Xarelto was first approved by the FDA in 2011, the popularity of the oral medication has soared.